The Secret Terms of Trump’s Venezuelan Oil Deal
The Trump administration committed the U.S. to taking a large stake in a Venezuelan company, some of whose owners and investors are shielded from public view. The exact details of the agreement over o...
Polish parliament votes to liberalize abortion access
Two bills to liberalize abortion laws, backed by pro-European Prime Minister Donald Tusk's governing coalition, were voted through on October 20, though conservative-nationalist President Karol Nawrocki is expected to veto them.
US has resumed sharing intelligence with Ukraine about Russian strikes, says Zelenskyy
Advance warnings of missile attacks were seemingly suspended last week by the White House, but Ukraine’s president says: ‘Now it works’ The US has resumed sharing intelligence with Kyiv about Russian missile strikes, Volodymyr Zelenskyy said on Tuesday after a meeting with the US envoy Steve Witkoff in Norway. Zelenskyy said Ukraine was again receiving advance warnings of ballistic missile attacks, which were seemingly suspended last week by the White House. “Now it works. It’s great,” he said, saying the US move would save lives. Continue reading...
Pollster admits to fabricating data for ‘social experiment’ to expose flaws of industry
Wedgewood Polls said project was designed to highlight lack of scrutiny over polling sector by mainstream media A polling firm has admitted to using fabricated data in surveys that were picked up by national media outlets in the US, claiming the project was a “social experiment” designed to expose the lack of scrutiny over the sector. Wedgewood Polls released a statement on Tuesday on social media, after polling and election analysis site FiftyPlusOne reached out for comment on an investigation it had conducted into their surveys and data. Continue reading...
Controversial US-backed vaccine trial in African newborns halted
Hepatitis B study in Guinea-Bissau that was to be funded by CDC and that drew global backlash ‘will not move forward’ The US-backed hepatitis B vaccine trial in African newborns that drew global backlash was halted, the lead researcher said on Wednesday. It is “now clear” that the study “will not move forward in Guinea-Bissau”, Frederik Schaltz-Buchholzer, a Danish researcher, wrote on LinkedIn, adding, “we were not given the necessary governmental approval.” Continue reading...
Log in or sign up to comment.